Amphion Innovations plc (LSE: "AMP") Announces First Annual Science & Business Symposium "Building Market Value from the World of Genetics".Featured Speakers Include Amphion Innovations plc & Partner Company CEOs NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- As a result of the mapping of the human genome The human genome is the genome of Homo sapiens, which is composed of 24 distinct pairs of chromosomes (22 autosomal + X + Y) with a total of approximately 3 billion DNA base pairs containing an estimated 20,000–25,000 genes. , genetic research is impacting scientific discovery in profound ways. This includes everything from understanding the underlying causes of diseases to the regulation of cellular functions, faster disease detection and the creation of new drugs. To speak about these topics, CEOs from Myconostica, Ltd., Motif BioSciences, Inc. and WellGen, Inc. will share exciting new research trends from the world of genetics. The Genetics Symposium is sponsored by Amphion Innovations, plc, (LSE LSE - Language Sensitive Editor : AMP) a developer of companies planning to commercialize intellectual property in life sciences and technology. Amphion's management team has created more than US $14B in aggregate market capitalization Market Capitalization A measure of a public company's size. Market capitalization is the total dollar value of all outstanding shares. It's calculated by multiplying the number of shares times the current market price. This term is often referred to as market cap. and has played an instrumental role in co-founding companies, such as Celgene (NASD NASD See: National Association of Securities Dealers NASD See National Association of Securities Dealers (NASD). : CELG) and Medisense (NYSE NYSE See: New York Stock Exchange : ABT ABT About ABT Abteilung (German: Department) ABT Abbott Laboratories (stock symbol) ABT American Ballet Theatre ABT Associação Brasileira de Telemarketing ABT Abort ABT Availability Based Tariff ). WHAT: Amphion Innovations plc, a developer of life science and technology businesses, will introduce the work of its Partner Companies and showcase its proven model for commercializing highly disruptive IP. WHO: Mr. Richard Morgan, CEO Amphion Innovations plc will describe Amphion's approach to building $100 million plus businesses in the UK and US markets Dr. David Denning, CEO Myconostica, Ltd. will speak on the use of molecular genetics for rapid diagnosis of deadly infections Mr. Zaki Hosny, CEO Motif BioSciences, Inc. will speak on how population genetics is being used to isolate certain disease mutations, such as diabetes and autism Dr. Kathleen Mullinix, CEO WellGen, Inc. will discuss developing functional foods and screening for natural ingredients that affect gene expression WHERE: American Conference Centers, 780 Third Avenue (48/49 St.) New York City WHEN: May 15th, from 4:30-7:00 PM. Refreshments will be served. To confirm your presence at the symposium or to receive additional information, please contact: Nicole Allen/Josh Berkman (646) 747-7161 or (917) 528-1066/(646) 747-7158 or 718-490-6905 nallen@kwitco.com/jberkman@kwitco.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion